A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
Randomized, Open-labeled, Single Dosing Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 healthy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 2, 2009
CompletedFirst Posted
Study publicly available on registry
November 4, 2009
CompletedDecember 24, 2009
December 1, 2009
1 month
November 2, 2009
December 23, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cmax, Tmax, AUC, T1/2, CL/F etc.
0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24 hours
Study Arms (2)
Group B
ACTIVE COMPARATORPeriod 1: fed control → Period 2: fasted control
Group A
ACTIVE COMPARATORPeriod 1: fasted control → Period 2: fed control
Interventions
Period 1: administration of fimasartan 240mg at 9:00am, 30 minutes after the breakfast Period 2: administration of fimasartan 240mg at 9:00am, without the breakfast
Eligibility Criteria
You may qualify if:
- age: 20 - 45 years
- sex: male
- body weight: greater than 55 kg
- written informed consent
You may not qualify if:
- known allergy to Fimasartan
- existing cardiac or hematological diseases
- existing hepatic and renal diseases
- existing gastrointestinal diseases
- acute or chronic diseases which could affect drug absorption or metabolism history of any serious psychological disorder
- abnormal diet which could affect drug absorption or metabolism
- positive drug or alcohol screening
- smokers of 10 or more cigarettes per day
- participation in a clinical trial during the last 60 days prior to the start of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 2, 2009
First Posted
November 4, 2009
Study Start
October 1, 2009
Primary Completion
November 1, 2009
Last Updated
December 24, 2009
Record last verified: 2009-12